Your browser doesn't support javascript.
loading
Aldosterone-producing nodules and CYP11B1 signaling correlate in primary aldosteronism.
Lin, Jui-Hsiang; Peng, Kang-Yung; Kuo, Yu-Ping; Liu, Hsuan; Tan, Chin-Ming Bertrand; Lin, Yuh-Feng; Chiu, Hui-Wen; Lin, Yen-Hung; Chen, Yung-Ming; Chueh, Jeff S; Wu, Vin-Cent.
Afiliação
  • Lin JH; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Peng KY; TAIPAI, Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group, Taipei, Taiwan.
  • Kuo YP; TAIPAI, Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group, Taipei, Taiwan.
  • Liu H; Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Tan CB; Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.
  • Lin YF; Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.
  • Chiu HW; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Lin YH; Department of Cell and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Chen YM; Division of Colon and Rectal Surgery, Lin-Kou Medical Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Chueh JS; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Wu VC; Department of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Endocr Relat Cancer ; 29(2): 59-69, 2022 01 10.
Article em En | MEDLINE | ID: mdl-34821221

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenoma Adrenocortical / Aldosterona / Hiperaldosteronismo Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Endocr Relat Cancer Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenoma Adrenocortical / Aldosterona / Hiperaldosteronismo Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Endocr Relat Cancer Ano de publicação: 2022 Tipo de documento: Article